Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

Por Punt, C. J., Humblet, Y., Roca, E., Dirix, L. Y., Wainstein, R., Polli, A., Corradino, I.
Publicado em 1996

Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies

Por Mandalà, M, Grosso, F, Vitalini, C, Corradino, I, Sanfilippo, R, Colombini, S, Clerici, M, Labianca, R, De Pascale, A, Marsoni, S
Publicado em 2012